Locust Walk Acquisition Corp.
PROPOSED BUSINESS COMBINATION: eFFECTOR Therapeutics, Inc.
ENTERPRISE VALUE: $419 million
ANTICIPATED SYMBOL: EFTR
Locust Walk Acquisition Corp. proposes to combine with eFFECTOR Therapeutics, Inc., a biopharmaceutical company focused on pioneering the development of selective translation regulation inhibitors (STRIs) for the treatment of cancer. ...READ MORE
